Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Akram Hasanpour"'
Publikováno v:
Materials scienceengineering. C, Materials for biological applications. 118
Streptokinase, a clot-dissolving agent, is widely used in treatment of cardiovascular diseases such as blood clots and deep thrombosis. Streptokinase is a cost-effective drug with a short biological half-life (i.e. 15 to 30 min). In addition, due to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83c348f7750806e6d16498c794877d47
https://pubmed.ncbi.nlm.nih.gov/33255024
https://pubmed.ncbi.nlm.nih.gov/33255024
Autor:
Ahmad Vaez, Arian Ehterami, Vajiheh T. Nooshabadi, Saeed Farzamfar, Hengameh Razavi, Jafar Ai, Majid Salehi, Niloufar Nazeri, Hamed Sahrapeyma, Shilan Shafei, Akram Hasanpour
Publikováno v:
Journal of cellular physiology. 234(8)
Acute renal failure (ARF) is a clinical challenge that is highly resistant to treatment, and its high rate of mortality is alarming. Ischemia-reperfusion injury (IRI) is the most common cause of ARF. Especially IRI is implicated in kidney transplanta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db25fd0dbc7fad2857e673a61e3613e2
https://pubmed.ncbi.nlm.nih.gov/30609022
https://pubmed.ncbi.nlm.nih.gov/30609022